Clinical Trials Browser

Cervical Esophagus Adenocarcinoma

Carcinoma, Transitional Cell

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Pancreatic Neoplasms

Urinary Bladder Neoplasms

Adenocarcinoma Of Esophagus

Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Pancreatic Neoplasms, Neoplasms, Basal Cell

Rectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Oropharyngeal Neoplasms

Carcinoma, Hepatocellular

Esophageal Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Rectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Small Bowel Adenocarcinoma

Squamous Cell Carcinoma of Head and Neck

Stomach Neoplasms

Locally Advanced Rectal Cancer

Pancreatic Neoplasms

Colorectal Neoplasms

Anus Neoplasms

Rectal Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms

Rectal Neoplasms

Pancreatic cancer, adult, Pancreatic Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Colorectal Cancer Metastatic

Stomach Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Appendiceal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Carcinoma, Pancreatic Neoplasms

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

Carcinoma, Hepatocellular

Breast Neoplasms, Head and Neck Neoplasms, Colorectal Neoplasms

Gastrointestinal Neoplasms

Adenocarcinoma

BRAF V600 Colorectal Cancer

Stomach Neoplasms

Clinical Trials

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

LAP100

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

PANGEA

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

FRUITFUL

Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

TRIBE-C

PANCREAS

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

FOBEAR

RePaIr-HN

Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors

REDUCE

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

SMART TNT

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

CAPRI-3 GOIM

Adaptive Radiation in Anal Cancer

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.

PANC

Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab

Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis

CEIL

AIO-KRK-0418

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

AtezoTRIBE2

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

GRACIE

Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular Carcinoma

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer

I-FLOAT

Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer

BIG